Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

Will develop relationships with key opinion leaders in region

ABPI Colette GoldrickThe Association of the British Pharmaceutical Industry (ABPI) has appointed Pfizer Europe's former head of head of public affairs and policy Colette Goldrick as its first Northern Ireland director.

A native of Northern Ireland, Goldrick will be tasked with the identification, establishment and development of relationships with key opinion leaders and decision makers in the nation.

“The ABPI believes that Northern Ireland represents a significant opportunity for the bio-pharmaceutical industry in terms of the growing life science agenda, arising from world class capability at Queen's University Belfast, the University of Ulster and the Science Park,” said the ABPI's chief executive Stephen Whitehead.

“Our partnership based approach will seek to engage all stakeholders in supporting healthcare professionals to effectively utilise innovative medicines and improve patient health.”

Goldrick has a strong pedigree within the pharma industry, serving in senior positions in public affairs and communications at both Pfizer and GlaxoSmithKline.

Prior to her most recent role at Pfizer, she was Pfizer UK's head of communications and corporate affairs director. During her time at the pharma giant, she won Communiquétor of the Year at the Communiqué Awards 2008. At GSK, Goldrick served in several roles, rising to head of communications.

6th November 2012

From: Sales, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...